Human Gene Therapy Clinical Development
SJR0.610
US
USJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2022 | — | — | 0.610 | Q3 | 72.6% | |
| 2021 | — | — | 0.783 | Q3 | 80.6% | |
| 2020 | — | — | 0.956 | Q2 | 84.3% | |
| 2019 | — | — | 0.863 | Q3 | 82.2% | |
| 2018 | — | — | 0.827 | Q3 | 79.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2324-8637
ISSN
2324-8645
country
UScoverage
2013-2019